We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
-11.9%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.02B
AUM Growth
-$224M
(-18%)
Cap. Flow
-$66M
Cap. Flow
% of AUM
-6.44%
Top 10 Holdings %
Top 10 Hldgs %
37.29%
Holding
460
New
60
Increased
97
Reduced
133
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$40.3M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$31.8M |
| 3 |
Ovintiv
OVV
|
+$27M |
| 4 |
Apple
AAPL
|
+$11.9M |
| 5 |
Cigna
CI
|
+$8.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$34.5M |
| 2 |
Antero Resources
AR
|
+$25.9M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$24M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$14.9M |
| 5 |
HCA Healthcare
HCA
|
+$13.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 35.74% |
| 2 | Healthcare | 12.12% |
| 3 | Technology | 11.16% |
| 4 | Financials | 9.37% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
MGIC Investment
MTG
$6.27B
| $517K | 0.05% |
41,005
+18,548
| +83% | +$244K |
|
227
Stellus Capital Investment Corp
SCM
$203M
| $512K | 0.05% |
45,977
-2,824
| -6% | -$36.5K |
|
|
PDCO
228
DELISTED
Patterson Companies, Inc.
PDCO
| $510K | 0.05% |
16,830
+3,109
| +23% | +$97.4K |
|
229
Recursion Pharmaceuticals
RXRX
$1.57B
| $503K | 0.05% |
+61,804
| New | +$414K |
|
230
NextEra Energy
NEE
$187B
| $502K | 0.05% |
6,485
+2,515
| +63% | +$191K |
|
231
Inspired Entertainment
INSE
$177M
| $498K | 0.05% |
57,891
+37,483
| +184% | +$382K |
|
232
Capital Southwest
CSWC
$1.46B
| $497K | 0.05% |
26,985
+2,331
| +9% | +$51.3K |
|
233
Flowers Foods
FLO
$1.64B
| $486K | 0.05% |
+18,461
| New | +$486K |
|
234
Sweetgreen
SG
$713M
| $478K | 0.05% |
41,052
-39,949
| -49% | -$843K |
|
235
Twist Bioscience
TWST
$5.62B
| $473K | 0.05% |
+13,552
| New | +$480K |
|
236
AEON Biopharma
AEON
$11.1M
| $468K | 0.05% |
662
-1,404
| -68% | -$991K |
|
237
Ginkgo Bioworks
DNA
$481M
| $450K | 0.04% |
4,723
+2,268
| +92% | +$277K |
|
|
VRTV
238
DELISTED
VERITIV CORPORATION
VRTV
| $449K | 0.04% |
4,138
-12,438
| -75% | -$1.69M |
|
239
Gentherm
THRM
$1.31B
| $448K | 0.04% |
7,179
-8,840
| -55% | -$595K |
|
240
Moelis & Co
MC
$4.98B
| $445K | 0.04% |
11,311
+4
| +0% | +$174 |
|
241
Xencor
XNCR
$1.44B
| $445K | 0.04% |
+16,269
| New | +$401K |
|
|
SCRMU
242
DELISTED
Screaming Eagle Acquisition Corp. Unit
SCRMU
| $445K | 0.04% |
45,830
| – | – |
|
243
CarGurus
CARG
$3.01B
| $439K | 0.04% |
+20,410
| New | +$604K |
|
244
Generac Holdings
GNRC
$11.9B
| $437K | 0.04% |
2,076
+788
| +61% | +$194K |
|
245
Direxion Daily Real Estate Bear 3X ETF
DRV
$25M
| $433K | 0.04% |
+8,607
| New | +$372K |
|
246
Spire
SR
$4.92B
| $423K | 0.04% |
+5,687
| New | +$428K |
|
247
EXL Service
EXLS
$4.23B
| $413K | 0.04% |
+14,000
| New | +$396K |
|
248
ATI
ATI
$27B
| $412K | 0.04% |
18,161
-75,867
| -81% | -$2M |
|
249
Omnicell
OMCL
$1.86B
| $412K | 0.04% |
+3,621
| New | +$416K |
|
250
Legend Biotech
LEGN
$4.3B
| $411K | 0.04% |
+7,471
| New | +$315K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q2 2022 Portfolio in Review
As of Q2 2022, Advisory Research held 460 positions worth $1.02B, down 18% from $1.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Advisory Research withdrew a net $66M in Q2 2022, closing 90 positions and reducing 133 holdings. Its most notable exit was Coterra Energy, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Energy at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Advisory Research opened a new position in Enerplus Corporation worth $38.7M.
- Advisory Research's largest Q2 2022 buy was Enerplus Corporation: 2,926,378 shares worth $38.7M.
- Advisory Research added most to Ovintiv in Q2 2022, an estimated $27M increase.
- Advisory Research's biggest Q2 2022 reduction was Devon Energy, cutting an estimated $34.5M.
- Advisory Research fully exited Coterra Energy in Q2 2022, selling an estimated $24M.
- Advisory Research's ten largest holdings make up 37% of its $1.02B portfolio in Q2 2022.
- Advisory Research opened 60 new positions and closed 90 in Q2 2022.
- Advisory Research's portfolio value fell 18% quarter-over-quarter to $1.02B.
Based on Advisory Research's 13F filing for Q2 2022, filed 15 Aug 2022.